PRACTICAL UTILITY OF “GILOY KWATH” AND “AYUSH KWATH” IN THE MANAGEMENT OF COVID-19 INFECTION-RELATED SYMPTOMS
Dr. Roopendra Singh Bhati* and Prof. A. Rama Murthy
The SARS-CoV-2 virus is the infectious disease known as coronavirus disease (COVID-19). SARS-CoV-2 severe acute respiratory syndrome has developed into a pandemic. Being a novel virus, the pathogenesis of the disease causation is not fully understood, and drugs against this virus are still being tested, Consequently, there isn't an effective treatment at the moment. The research finding suggests that many Ayurved herbal drugs possess immune-modulatory, anti-inflammatory, and antiviral properties can be a turning point in the prevention and management of COVID-19. Reviewing the role of immunity in the pathogenesis of COVID-19, as well as ‘Giloy kwath’ and ‘Ayush Kwath’ significance in combating the virus and the regulation of immunity, is our intent in this literature study. The current review was carried out using a search of the available literature on COVID-19 and immunity, Ayurveda and COVID-19, Vyadhikshamatwa, Rasayana, and immunomodulatory effects of medicinal plants, including Guduchi (Tinospora cordifolia Willd.) Sunthi/Ginger(Zingiber officinale Rosc.), Marich/Black Pepper/(Piper nigrum Linn.), Dalchini (Cinnamomum zeylanicum Breyn.) and Tulsi/Holy Basil(Ocimum sanctum Linn.). Since ancient times, ayurveda and traditional remedies have significantly aided in the prevention and treatment of numerous communicable and noncommunicable diseases. Numerous therapeutic methods, such as Rasayana, Satwawajaya, Yuktivyapashraya, Vyadhi Viparitarthakari chikitsa, etc. can be used to accomplish Guduchi kwath and Ayush Kwath immune-promoting and disease-alleviating characteristics. Guduchi kwath as well as Ayush Kwath appears to be useful in regulating immunity for the prevention and mitigation of viral illness sequelae because of its antipyretic, antiviral, immune-modulatory, antioxidant, anti-inflammatory, anti-platelet, anti-atherosclerotic, hepatoprotective, and reno-protective qualities. The efficiency of these formulations must be confirmed via substantial biotechnological, pharmacological, and clinical research because there is insufficient data to establish their specific role against coronavirus.
[Full Text Article]